Mechanical Aortic Valve Without Anticoagulation or Mechanical Failure for 24 Years

Area of Science:

• Cardiovascular Surgery
• Biomaterials Science
• Clinical Cardiology

Background:

• Current guidelines recommend lifelong anticoagulation for patients with mechanical aortic valves to prevent thromboembolic events.
• Evidence exploring outcomes without anticoagulation post-mechanical aortic valve replacement is limited.
• Mechanical aortic valve prostheses are associated with a risk of thrombosis and embolism.

Observation:

• This case study details a patient who discontinued warfarin therapy two years after a mechanical aortic valve replacement.
• The patient was followed for 24 years post-discontinuation of anticoagulation.
• No thromboembolic events or mechanical valve failure were observed during the follow-up period.

Findings:

• A patient with a mechanical aortic valve replacement successfully remained without anticoagulation for 24 years.
• Absence of anticoagulation did not lead to thromboembolic complications or valve malfunction in this specific case.
• This outcome contrasts with established clinical guidelines for mechanical valve management.

Implications:

• This case suggests a potential need to re-evaluate current anticoagulation guidelines for select mechanical aortic valve recipients.
• Further research is warranted to identify patient subgroups who might safely avoid lifelong anticoagulation.
• Long-term outcomes without anticoagulation could offer insights into alternative management strategies for mechanical heart valves.